| 000 | 01630 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515061541.0 | ||
| 264 | 0 | _c20070727 | |
| 008 | 200707s 0 0 eng d | ||
| 022 | _a0009-9236 | ||
| 024 | 7 |
_a10.1038/sj.clpt.6100148 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFrassetto, L A | |
| 245 | 0 | 0 |
_aEffects of uptake and efflux transporter inhibition on erythromycin breath test results. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cJun 2007 |
||
| 300 |
_a828-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_a2-Pyridinylmethylsulfinylbenzimidazoles _xpharmacology |
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBreath Tests _xmethods |
| 650 | 0 | 4 | _aCarbon Radioisotopes |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aCytochrome P-450 CYP3A |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
| 650 | 0 | 4 | _aErythromycin |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLansoprazole |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOrganic Anion Transporters _xantagonists & inhibitors |
| 650 | 0 | 4 | _aProtein Synthesis Inhibitors |
| 650 | 0 | 4 |
_aRifampin _xpharmacology |
| 650 | 0 | 4 | _aSex Factors |
| 700 | 1 | _aPoon, S | |
| 700 | 1 | _aTsourounis, C | |
| 700 | 1 | _aValera, C | |
| 700 | 1 | _aBenet, L Z | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 81 _gno. 6 _gp. 828-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.clpt.6100148 _zAvailable from publisher's website |
| 999 |
_c16916693 _d16916693 |
||